Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s

Levofloxacin AUC<sub>0-12</sub> was lower in the second trimester than the third trimester of pregnancy and the postpartum period, but exposures overall were within target ranges. Further research is warranted to explore the clinical significance of these findings.

Authors

Institutions

Publication Details

Journal
Clinical Pharmacokinetics
Published
2025-03-28
DOI
https://doi.org/10.1007/s40262-025-01498-0
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s

Marije Van Schalkwyk, Anneke Catharina Hesseling, Ahizechukwu Chigoziem Eke, Petra De Koker et al.
Clinical Pharmacokinetics
Tuberculosis Research and Epidemiology
article

Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s

Marije Van Schalkwyk, Anneke Catharina Hesseling, Ahizechukwu Chigoziem Eke, Petra De Koker, James S. Ngocho, David E. Shapiro, Lubbe Wiesner, Jennifer Hughes, Mauricio Pinilla, Kevin Knowles, Kristina M. Brooks, Nahida Chakhtoura, Brookie M. Best, Kathleen George, Eric H. Decloedt, Lee Fairlie, Alice Marie Stek, Renee Browning, Mark Mirochnick
article en

Abstract

Levofloxacin AUC<sub>0-12</sub> was lower in the second trimester than the third trimester of pregnancy and the postpartum period, but exposures overall were within target ranges. Further research is warranted to explore the clinical significance of these findings.

Clinical PharmacokineticsVol. 64(4)
Boston University (US), University of Southern California (US), Family Health International 360 (US), National Institutes of Health (US), Desmond Tutu HIV Foundation (ZA), Johns Hopkins University (US), University of Cape Town (ZA), University of the Witwatersrand (ZA), Stellenbosch University (ZA), Johns Hopkins Medicine (US), Tygerberg Hospital (ZA), University of California San Diego (US), Rady Children's Hospital-San Diego (US), Cancer Research And Biostatistics (US), National Institute of Allergy and Infectious Diseases (US), Kilimanjaro Christian Medical Centre (TZ), Frontier Science & Technology Research Foundation, Inc. (US), Eunice Kennedy Shriver National Institute of Child Health and Human Development (US), University of Colorado Anschutz Medical Campus (US)
International Maternal Pediatric Adolescent AIDS Clinical Trials Network, Universiteit Stellenbosch, University of Cape Town, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Openalex Percentile: Top 91%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.